Speeding Patient Recruitment by Perfecting Site Identification and Activation

Leveraging our deep expertise in clinical trials, we found that objective data has the best chance of optimizing a trial's start-up and getting medicines to patients as fast as possible. We built an algorithm to access, extract, normalize, index, and integrate data on over 100,000 global investigators to create a customizable site identification platform.

AcceleTrial™ is a Study Start-Up System (SSUS) that combines site identification, feasibility, and site activation to drastically speed the start-up of clinical trials.  

Expertise • Experience • Patients

WHAT WE BELIEVE

The greatest opportunity to improve clinical trials is through site start-up.

The only way to have a meaningful and measurable impact on site start-up is through more accurate, objective, evidence based site identification.

That's why we created AcceleTrial™.

WHAT CAN YOU DO

1

Identification

Use evidence-based data to target sites with the right patients for your trial

2

Feasibility Questionnaire

Access responses in real-time for quick insight on your site’s capability to conduct the trial

3

Site Visit

Schedule dates for Pre-Study Site Visit and Site Initiation Visit to qualify sites, and provide training

4

Clinical Trial Agreement

Expedite contracts and initiate sites to accelerate patient enrollment

5

Regulatory / IRB

View regulatory essential documents and manage IRB/Ethics approvals

6

Drug Shipment

Monitor drug request and shipment

7

Enrollment

Track screening and enrollment to confirm activation

SITE PROCESS

WHAT CAN YOU DO

1

CDA

Expedite the Confidential Disclosure Agreement with auto-fills and digital signature

2

Feasibility Questionnaire

Immediate access to questionnaires to provide insights on site capability

3

Qualification

Provide required documents and coordinate sponsor visits

4

Clinical Trial Agreement

Facilitate negotiations on contracts with accuracy and clear communication

5

Regulatory / IRB

Upload essential regulatory documents and track IRB/Ethics submission and approvals

6

Enrollment

Report and track screening and enrollment to confirm activation

Testimonials

Clients

We are proud to be  recognized by MD Tech Review for our advancements in the clinical space!

To learn more about our first-of-its-kind Study Start-Up System (SSUS) and read the Q&A with our Founder and President, please click here.